albuterol

(redirected from AccuNeb)
Also found in: Thesaurus, Medical.
Related to AccuNeb: Albuterol sulfate

al·bu·ter·ol

 (ăl-byo͞o′tə-rôl′)
n.
A beta-adrenergic drug, C13H21NO3, used in the form of its sulfate as a bronchodilator primarily to treat asthma and chronic obstructive pulmonary disease. Also called salbutamol.

[al(pha) + blend of but(yl) and -terol (ultimately shortening of (ar)terenol, norepinephrine hydrochloride, originally a trademark).]

albuterol

(ælˈbjuːtəˌrɒl)
n
a bronchodilator used by sufferers of asthma, emphysema, and other lung conditions, to treat symptoms such as wheezing or shortness of breath
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.albuterol - a bronchodilator (trade names Ventolin or Proventil) used for asthma and emphysema and other lung conditionsalbuterol - a bronchodilator (trade names Ventolin or Proventil) used for asthma and emphysema and other lung conditions; available in oral or inhalant forms; side effects are tachycardia and shakiness
bronchodilator - a drug that relaxes and dilates the bronchial passageways and improves the passages of air into the lungs
Translations

albuterol

n salbutamol m, albuterol m
References in periodicals archive ?
Corona CA) won approval to market its generic version of Dey LP's AccuNeb Inhalation Solution, which treats bronchospasm in patients 2 to 12 years of age with asthma.
PARI is the only nebulizer company that has demonstrated clinical success in trials for Xopenex, Brovana, DuoNeb, AccuNeb, Perforomist, TOBI, and Cayston.
PARI reusable nebulizers are considered the gold standard for clinical trials and are recommended in commercial sales including AstraZeneca's Pulmicort Respules, Sepracor's Xopenex and Brovana, Novartis' TOBI, Genentech's Pulmozyme, and DEY LP's Accuneb, Duoneb, and Perforomist.